Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 14;10(7):e034947.
doi: 10.1136/bmjopen-2019-034947.

Protocol for a single-arm confirmatory trial of adjuvant chemoradiation for patients with high-risk rectal submucosal invasive cancer after local resection: Japan Clinical Oncology Group Study JCOG1612 (RESCUE study)

Tomohiro Kadota  1   2 , Hiroaki Ikematsu  3 , Takeshi Sasaki  4 , Yutaka Saito  5 , Masaaki Ito  4 , Tomonori Mizutani  6 , Gakuto Ogawa  1 , Kohei Shitara  2 , Yoshinori Ito  7 , Ryoji Kushima  8 , Yukihide Kanemitsu  9 , Manabu Muto  10
Affiliations

Protocol for a single-arm confirmatory trial of adjuvant chemoradiation for patients with high-risk rectal submucosal invasive cancer after local resection: Japan Clinical Oncology Group Study JCOG1612 (RESCUE study)

Tomohiro Kadota et al. BMJ Open. .

Abstract

Introduction: Intestinal resection with lymph node dissection is the current standard treatment for high-risk lower rectal submucosal invasive cancer after local resection; however, surgery affects patients' quality of life due to stoma placement or impaired anal sphincter function. A recent study demonstrated that adjuvant chemoradiation yields promising results.

Methods and analysis: This study aims to confirm the non-inferiority of adjuvant chemoradiation, consisting of capecitabine and concurrent radiotherapy (45 Gy in 25 fractions), measured by 5-year relapse-free survival (RFS), over standard surgery in patients with high-risk lower rectal submucosal invasive cancer after local resection. The primary endpoint is 5 year RFS. The secondary endpoints are 10 years RFS, 5-year and 10-year overall survival, 5-year and 10-year local RFS, 5-year and 10-year proportion of anus-preservation without stoma, Wexner score, low anterior resection syndrome score, adverse events and serious adverse events. During the 5-year trial period, 210 patients will be accrued from 65 Japanese institutions.

Ethics and dissemination: The National Cancer Center Hospital East Certified Review Board approved this study protocol in October 2018. The study is conducted in accordance with the precepts established in the Declaration of Helsinki and Clinical Trials Act. Written informed consent will be obtained from all eligible patients prior to registration. The primary results of this study will be published in an English article. In addition, the main results will be published on the websites of Japan Clinical Oncology Group (www.jcog.jp) and jRCT (https://jrct.niph.go.jp/). As to data curation, it has not been prepared yet.

Trial registration number: jRCT1031180076.

Keywords: endoscopy; gastroenterology; gastrointestinal tumours; radiation oncology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: KS reports grants from reports research funding from Chugai.

Similar articles

See all similar articles

Cited by

References

    1. Watanabe T, Muro K, Ajioka Y, et al. . Japanese Society for cancer of the colon and rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol 2018;23:1–34. 10.1007/s10147-017-1101-6 - DOI - PMC - PubMed
    1. Ueno H, Mochizuki H, Hashiguchi Y, et al. . Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004;127:385–94. 10.1053/j.gastro.2004.04.022 - DOI - PubMed
    1. Kitajima K, Fujimori T, Fujii S, et al. . Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol 2004;39:534–43. 10.1007/s00535-004-1339-4 - DOI - PubMed
    1. Ikematsu H, Yoda Y, Matsuda T, et al. . Long-Term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterology 2013;144:551–9. quiz e14. 10.1053/j.gastro.2012.12.003 - DOI - PubMed
    1. Kakodkar R, Gupta S, Nundy S. Low anterior resection with total mesorectal excision for rectal cancer: functional assessment and factors affecting outcome. Colorectal Dis 2006;8:650–6. 10.1111/j.1463-1318.2006.00992.x - DOI - PubMed

Publication types

Substances